Skip to main content
Watch Insiders
URGN filings

Corporate insider profile

Mark Schoenberg Filing Activity

Latest reported as Chief Medical Officer of UroGen Pharma Ltd. (URGN).

Purchase filings
0
Reported companies
1
Net open-market value
-$792,660.60
Latest transaction
Jun 22, 2026

Affiliated corporations

Reported company relationships

URGNLatest reported

UroGen Pharma Ltd.

Chief Medical Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 22, 2026UroGen Pharma Ltd. (URGN)Chief Medical OfficerSale10,000$35.01$350,100
Jun 8, 2026UroGen Pharma Ltd. (URGN)Chief Medical OfficerSale5,222$27.30$142,561
May 8, 2026UroGen Pharma Ltd. (URGN)Chief Medical OfficerSale10,000$30.00$300,000